{"id":32502,"date":"2025-06-18T16:56:08","date_gmt":"2025-06-18T11:26:08","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=32502"},"modified":"2025-06-18T16:59:03","modified_gmt":"2025-06-18T11:29:03","slug":"exploring-life-saving-heart-devices-innovations-transforming-cardiac-care","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care","title":{"rendered":"Exploring Life-Saving Heart Devices: Innovations Transforming Cardiac Care"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_76 counter-hierarchy ez-toc-counter ez-toc-white ez-toc-container-direction\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<label for=\"ez-toc-cssicon-toggle-item-6a045852f04e3\" class=\"ez-toc-cssicon-toggle-label\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/label><input type=\"checkbox\"  id=\"ez-toc-cssicon-toggle-item-6a045852f04e3\"  aria-label=\"Toggle\" \/><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care\/#Types_of_Heart_Devices\" >Types of Heart Devices<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care\/#Total_Artificial_Heart\" >Total Artificial Heart<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care\/#Heart_Sounds_SensorsElectronic_Stethoscope\" >Heart Sounds Sensors\/Electronic Stethoscope<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care\/#Heart_Pump_Device\" >Heart Pump Device<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care\/#Tissue_Heart_Valves\" >Tissue Heart Valves<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care\/#Transcatheter_Heart_Valve_Replacement_Devices\" >Transcatheter Heart Valve Replacement Devices<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care\/#Congestive_Heart_Failure_Treatment_Devices\" >Congestive Heart Failure Treatment Devices<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care\/#Structural_Heart_Devices\" >Structural Heart Devices<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care\/#Heart_Closure_Devices\" >Heart Closure Devices<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care\/#Congenital_Heart_Defect_Devices\" >Congenital Heart Defect Devices<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care\/#Recent_Developments_in_Heart_Devices\" >Recent Developments in Heart Devices<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care\/#Challenges_and_Benefits_of_Heart_Devices\" >Challenges and Benefits of Heart Devices<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care\/#Challenges\" >Challenges<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care\/#Benefits\" >Benefits<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care\/#Emerging_Technologies\" >Emerging Technologies<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care\/#Conclusion\" >Conclusion<\/a><\/li><\/ul><\/nav><\/div>\n\n<p><strong>Heart disease<\/strong> continues to be a major global health concern, impacting countless lives and placing a significant burden on healthcare systems worldwide. According to the World Health Organization, cardiovascular diseases are responsible for approximately <strong>17.9 million deaths each year,<\/strong> accounting for nearly one-third of all global deaths. These conditions, ranging from heart failure to congenital defects, demand innovative solutions to improve patient outcomes and quality of life.&nbsp;<\/p>\n\n\n\n<p>Heart devices have emerged as vital tools in this fight, offering advanced treatment options that manage symptoms, correct abnormalities, and, in many cases, save lives. From mechanical pumps to minimally invasive valves, these technologies represent the forefront of cardiac care. This blog provides a detailed exploration of various heart devices, their specific roles in treating cardiac conditions, recent advancements in the field, and the challenges and opportunities that lie ahead.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-types-of-heart-devices\"><span class=\"ez-toc-section\" id=\"Types_of_Heart_Devices\"><\/span>Types of Heart Devices<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>A wide range of heart devices has been developed to support, replace, or monitor cardiac function in patients with various cardiovascular conditions. These technologies play a crucial role in managing heart failure, rhythm disorders, and congenital defects, improving both survival and quality of life. Below are some of the key types of heart devices transforming cardiac care.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"282\" src=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/18163351\/Types-of-Heart-Devices-1024x282.png\" alt=\"Types-of-Heart-Devices\" class=\"wp-image-32503\" srcset=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/18163351\/Types-of-Heart-Devices-1024x282.png 1024w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/18163351\/Types-of-Heart-Devices-300x83.png 300w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/18163351\/Types-of-Heart-Devices-150x41.png 150w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/18163351\/Types-of-Heart-Devices-768x211.png 768w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/18163351\/Types-of-Heart-Devices-1536x422.png 1536w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/18163351\/Types-of-Heart-Devices-2048x563.png 2048w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-total-artificial-heart\"><span class=\"ez-toc-section\" id=\"Total_Artificial_Heart\"><\/span>Total Artificial Heart<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>The <a href=\"https:\/\/www.delveinsight.com\/report-store\/total-artificial-heart-market\"><strong>Total Artificial Heart (TAH)<\/strong><\/a> is an advanced mechanical device that fully replaces both ventricles of a failing heart. Implanted after the natural heart is removed, it uses two artificial ventricles to pump blood to the lungs and body, typically powered by an external console or portable battery unit. The TAH is engineered to replicate the heart\u2019s natural pumping rhythm.<\/p>\n\n\n\n<p>Primarily used as a bridge to transplant for patients with end-stage heart failure when both ventricles fail, and other treatments like ventricular assist devices are insufficient. In rare cases, it serves as a long-term solution for those ineligible for heart transplants. Designed with biocompatible materials to reduce rejection risks, it includes sensors to adjust pumping based on the body\u2019s needs, ensuring stable blood flow for critically ill patients.<\/p>\n\n\n\n<p>The <strong>total artificial heart market<\/strong> is expected to grow due to the increasing prevalence of end-stage heart failure and a shortage of donor hearts. Innovations in portable power systems and device durability, led by companies like <strong>SynCardia Systems<\/strong> and others, are key drivers of market expansion.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-heart-sounds-sensors-electronic-stethoscope\"><span class=\"ez-toc-section\" id=\"Heart_Sounds_SensorsElectronic_Stethoscope\"><\/span>Heart Sounds Sensors\/Electronic Stethoscope<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/heart-sounds-sensors-electronic-stethoscope-market\"><strong>Heart Sounds Sensors, or electronic stethoscopes<\/strong><\/a><strong>,<\/strong> are non-invasive devices that capture heart sounds with high precision using sensitive microphones and digital signal processing. They amplify and filter sounds to detect abnormalities like murmurs or irregular rhythms, often integrating with software for data visualization and storage.<\/p>\n\n\n\n<p>Used for early diagnosis of heart conditions such as <strong>valve dysfunction, heart murmurs, or pericarditis in clinical settings or via telemedicine, <\/strong>enabling timely intervention to prevent complications like heart failure. Heart sound sensors\/electronic stethoscopes offer digital amplification, noise reduction, and AI-powered analysis for enhanced diagnostic accuracy. Data recording and sharing capabilities support remote monitoring and collaborative diagnosis.<\/p>\n\n\n\n<p>The <strong>heart sound sensors market <\/strong>is expected to grow due to rising demand for non-invasive diagnostic tools and the expansion of telemedicine. Companies like <strong>GE Healthcare, Koninklijke Philips N.V., Welch Allyn, <\/strong>and others<strong> <\/strong>are driving innovation in this field.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-heart-pump-device\"><span class=\"ez-toc-section\" id=\"Heart_Pump_Device\"><\/span>Heart Pump Device<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/heart-pump-device-market\"><strong>Heart Pump Devices<\/strong><\/a><strong>,<\/strong> such as <a href=\"https:\/\/www.delveinsight.com\/report-store\/ventricular-assist-devices-vad-market\">Ventricular Assist Devices (VADs)<\/a>, are mechanical pumps that support a weakened heart by aiding blood circulation. They assist the left (LVAD), right (RVAD), or both ventricles (BiVAD), connected to the heart and powered by external batteries or control units, ensuring adequate blood flow.<\/p>\n\n\n\n<p>Used for <a href=\"https:\/\/www.delveinsight.com\/report-store\/advanced-heart-failure-market\"><strong>advanced heart failure patients<\/strong><\/a> as a bridge to heart transplant, recovery, or as destination therapy for non-transplant candidates. They alleviate symptoms like fatigue and shortness of breath, improving quality of life. Heart pump device features compact, durable designs with magnetically levitated systems for reduced wear and wireless monitoring for real-time patient data, enhancing treatment outcomes.<\/p>\n\n\n\n<p>Valued at <strong>USD 4.44 billion<\/strong> in 2023, the <strong>heart pump devices market <\/strong>is expected to reach <strong>USD 6.20 billion<\/strong> by 2032, growing at a <strong>CAGR <\/strong>of <strong>5.74%<\/strong> from 2025 to 2032, driven by rising heart failure cases, an aging population, and technological advancements by companies like <strong>Medtronic, Abiomed, Micropor<\/strong>t <strong>Scientific Corporation, <\/strong>and others.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-tissue-heart-valves\"><span class=\"ez-toc-section\" id=\"Tissue_Heart_Valves\"><\/span>Tissue Heart Valves<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/tissue-heart-valves-cardiovascular-prosthetic-devices-market\"><strong>Tissue Heart Valves<\/strong><\/a><strong> are bioprosthetic valves<\/strong> made from animal (e.g., <strong>porcine or bovine<\/strong>) or human donor tissue, designed to replace damaged heart valves. These valves restore normal blood flow and are implanted surgically or via minimally invasive methods.<\/p>\n\n\n\n<p>Used to treat valvular heart diseases, such as aortic or mitral valve stenosis, particularly for patients who prefer to avoid lifelong anticoagulation therapy required by mechanical valves, improving long-term outcomes. Biocompatible and durable, these valves mimic natural heart function, reducing the need for ongoing medication and minimizing complications like blood clots.<\/p>\n\n\n\n<p>The <strong>tissue heart valves market<\/strong> is estimated to grow at a <strong>CAGR <\/strong>of <strong>7.56%<\/strong> from 2025 to 2032, driven by increasing valvular disease prevalence, an aging population, and advancements in tissue engineering. Leading companies include <strong>Abbott, Boston Scientific Corporation, Edwards Lifesciences Corporation, <\/strong>and others.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-transcatheter-heart-valve-replacement-devices\"><span class=\"ez-toc-section\" id=\"Transcatheter_Heart_Valve_Replacement_Devices\"><\/span>Transcatheter Heart Valve Replacement Devices<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/transcatheter-heart-valve-replacement-devices-market\"><strong>Transcatheter Heart Valve Replacement Devices<\/strong><\/a> use a minimally invasive catheter-based approach to replace damaged heart valves, such as aortic or mitral valves. Delivered through blood vessels, typically via the femoral artery, these devices avoid the need for open-heart surgery.<\/p>\n\n\n\n<p>Primarily used to treat aortic stenosis or mitral valve regurgitation in high-risk patients, such as the elderly or those with comorbidities, offering a less invasive alternative with improved safety and recovery. Transcatheter heart valve replacement devices enable faster recovery, reduced complications, and precise valve placement, with advanced imaging and delivery systems ensuring optimal outcomes.<\/p>\n\n\n\n<p>The<strong> transcatheter heart valve replacement devices market <\/strong>is estimated to grow at a <strong>CAGR <\/strong>of <strong>13.75%<\/strong> from <strong>2025 <\/strong>to <strong>2032<\/strong>, driven by the rising prevalence of aortic stenosis, increasing adoption of minimally invasive procedures, and technological advancements in valve design and delivery systems. Leading companies include <strong>Medtronic, Boston Scientific Corporation, Edwards Lifesciences, Abbott, <\/strong>and others.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-congestive-heart-failure-treatment-devices\"><span class=\"ez-toc-section\" id=\"Congestive_Heart_Failure_Treatment_Devices\"><\/span>Congestive Heart Failure Treatment Devices<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/congestive-heart-failure-treatment-devices-market\"><strong>Congestive Heart Failure (CHF) Treatment Devices<\/strong><\/a>, such as <a href=\"https:\/\/www.delveinsight.com\/report-store\/cardiac-resynchronization-therapy-market\"><strong>Cardiac Resynchronization Therapy (CRT) <\/strong><\/a>devices and certain implantable pumps, are designed to improve heart function in patients with heart failure. CRT devices synchronize the contractions of the heart\u2019s ventricles to enhance pumping efficiency, while some pumps assist blood circulation.<\/p>\n\n\n\n<p>Used to manage symptoms of <a href=\"https:\/\/www.delveinsight.com\/report-store\/congestive-heart-failure-market\">congestive heart failure<\/a>, such as shortness of breath, fatigue, and fluid retention, improving heart efficiency and reducing hospitalizations for patients with moderate to severe heart failure. Congestive heart failure treatment devices provide tailored therapy with features like biventricular pacing for CRT devices and advanced monitoring to optimize heart function, significantly enhancing patient quality of life.<\/p>\n\n\n\n<p>Valued at <strong>USD 17.41 billion <\/strong>in <strong>2023<\/strong>, the congestive <strong>heart failure treatment devices market<\/strong> is expected to reach <strong>USD 27.96 billion<\/strong> by 2032, growing at a <strong>CAGR <\/strong>of <strong>8.26%<\/strong> from 2025 to 2032<strong>,<\/strong> driven by the increasing prevalence of heart failure, advancements in CRT technology, and growing adoption of implantable devices. Key players include <strong>GE HealthCare, Boston Scientific Corporation, Medtronic, Abbott, Biotronik SE &amp; Co. KG, <\/strong>and others.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-structural-heart-devices\"><span class=\"ez-toc-section\" id=\"Structural_Heart_Devices\"><\/span>Structural Heart Devices<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/structural-heart-devices-market-market\"><strong>Structural Heart Devices<\/strong><\/a> are specialized tools used to repair structural abnormalities in the heart, such as<strong> leaky valves,<\/strong> <strong>atrial septal defects (ASD)<\/strong>, or <strong>ventricular septal defects (VSDs)<\/strong>. These devices are typically delivered via minimally invasive, catheter-based procedures, avoiding the need for open-heart surgery.<\/p>\n\n\n\n<p>Used to treat conditions like ASD, VSD, or paravalvular leaks, restoring normal heart function and blood flow in patients with congenital or acquired structural heart issues, often improving symptoms and preventing complications like heart failure or stroke. Structural heart devices offer precise, minimally invasive repairs with advanced imaging for accurate placement, reducing recovery time and improving heart performance with fewer complications compared to traditional surgery.<\/p>\n\n\n\n<p>Valued at <strong>USD 9.81 billion<\/strong> in <strong>2023<\/strong>, the structural heart devices market is expected to reach<strong> USD 18.67 billion <\/strong>by 2032, growing at a <strong>CAGR <\/strong>of <strong>11.33%<\/strong> from 2025 to 2032, driven by the rising prevalence of structural heart diseases, increasing adoption of minimally invasive techniques, and advancements in device technology. Key players include <strong>Medtronic, Boston Scientific Corporation, Edwards Lifesciences, W. L. Gore &amp; Associates, Inc.,<\/strong> and others.\u00a0<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-heart-closure-devices\"><span class=\"ez-toc-section\" id=\"Heart_Closure_Devices\"><\/span>Heart Closure Devices<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/heart-closure-devices-market\"><strong>Heart Closure Devices<\/strong><\/a> are implants designed to seal holes or defects in the heart, such as <a href=\"https:\/\/www.delveinsight.com\/report-store\/patent-foramen-ovale-closure-devices-market\"><strong>patent foramen ovale (PFO)<\/strong><\/a> or <strong>atrial septal defects (ASD).<\/strong> Delivered via minimally invasive catheter-based procedures, these devices close abnormal openings to restore normal blood flow.<\/p>\n\n\n\n<p>Used to prevent abnormal blood flow that can lead to stroke or heart failure, particularly in patients with congenital defects like PFO or ASD, offering a less invasive alternative to surgical repair. Heart closure devices provide high success rates in defect closure with biocompatible materials, ensuring quick recovery and improved heart function while reducing risks like stroke or embolism.<\/p>\n\n\n\n<p>Valued at <strong>USD 2.51 billion<\/strong> in <strong>2023<\/strong>, the market is expected to reach <strong>USD 3.99 billion <\/strong>by 2032, growing at a <strong>CAGR <\/strong>of <strong>6.85% <\/strong>from 2025 to 2032, driven by increasing awareness of stroke prevention, rising diagnoses of PFO and ASD, and advancements in minimally invasive closure technologies. Key players include <strong>Abbott, W. L. Gore &amp; Associates, Inc., Boston Scientific Corporation, Occlutech, <\/strong>and others.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-congenital-heart-defect-devices\"><span class=\"ez-toc-section\" id=\"Congenital_Heart_Defect_Devices\"><\/span>Congenital Heart Defect Devices<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/congenital-heart-defect-devices-market\"><strong>Congenital Heart Defect Devices<\/strong><\/a><strong> <\/strong>are specialized implants designed to correct structural abnormalities present at birth, such as <strong>ventricular septal defects (VSD)<\/strong>, atrial <strong>septal defects (ASD)<\/strong>, or <strong>patent ductus arteriosus (PDA)<\/strong>. These devices are often delivered via catheter-based procedures, tailored for pediatric or adult patients with complex heart anatomies.<\/p>\n\n\n\n<p>Used to treat congenital heart defects in children or adults, restoring normal heart function and blood flow to prevent complications like heart failure, pulmonary hypertension, or developmental issues, offering minimally invasive alternatives to open-heart surgery. Congenital heart defect devices feature precise, biocompatible designs suited for diverse anatomies, with advanced imaging for accurate placement, ensuring effective correction with minimal recovery time and improved long-term outcomes.<\/p>\n\n\n\n<p>The market is expected to grow due to advancements in pediatric cardiology, improved diagnostic techniques for early detection of congenital defects, and increasing demand for minimally invasive procedures. Key players include<strong> Abbott, Medtronic, and Edwards Lifesciences,<\/strong> focusing on tailored device innovations.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"has-text-align-center\">Revolutionize your heart device innovations with our MedTech and Diagnostics services, offering a resilient approach for a dynamic industry that helps improve reaction to uncertainties, develops an advantage over competitors, and improves overall PERFORMANCE in business.\u00a0<\/p>\n<\/blockquote>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"has-text-align-center\"><a href=\"https:\/\/www.delveinsight.com\/medical-devices\"><strong><em>Request for Proposal today<\/em><\/strong><\/a><strong><em> to lead in cardiac care solutions.<\/em><\/strong><\/p>\n<\/blockquote>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-recent-developments-in-heart-devices\"><span class=\"ez-toc-section\" id=\"Recent_Developments_in_Heart_Devices\"><\/span>Recent Developments in Heart Devices<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The cardiovascular device landscape continues to evolve rapidly with groundbreaking innovations aimed at improving diagnosis, treatment, and patient outcomes. From next-generation artificial hearts and AI-powered diagnostics to growth-adaptive pediatric stents and needle-free interventions, recent FDA approvals and clearances signal a strong shift toward more personalized, minimally invasive, and high-precision cardiac care. Below are some of the most notable updates from the past year.<\/p>\n\n\n\n<p><strong>June 2025<\/strong> \u2013 <em>Bivacor<\/em> received FDA Breakthrough Device Designation for its <strong>fully implantable titanium total artificial heart (TAH)<\/strong>, aimed at adults with severe biventricular or univentricular heart failure as a bridge to transplant (BTT), especially where LVADs are inadequate.<\/p>\n\n\n\n<p><strong>April 2025<\/strong> \u2013 <em>LUMA Vision Ltd.<\/em> gained FDA clearance for <strong>VERAFEYE\u2122<\/strong>, a catheter-based imaging platform offering real-time 360\u00b0 visualization for electrophysiology and structural heart procedures, with magnetic navigation compatibility.<\/p>\n\n\n\n<p><strong>April 2025<\/strong> \u2013 <em>CardioVia<\/em> received FDA clearance for its <strong>ViaOne system<\/strong>, enabling <strong>needle-free access to the pericardial space<\/strong>, reducing heart perforation risk during diagnostic and therapeutic interventions.<\/p>\n\n\n\n<p><strong>December 2024<\/strong> \u2013 <em>Johnson &amp; Johnson MedTech<\/em> secured FDA <strong>premarket approval (PMA)<\/strong> for its <strong>Impella 5.5 and Impella CP with SmartAssist heart pumps<\/strong> for pediatric patients with acute decompensated heart failure and cardiogenic shock.<\/p>\n\n\n\n<p><strong>November 2024<\/strong> \u2013 <em>BrightHeart<\/em> received <strong>FDA 510(k) clearance<\/strong> for its <strong>AI-powered prenatal ultrasound software<\/strong>, a breakthrough in fetal heart evaluation and prenatal cardiology.<\/p>\n\n\n\n<p><strong>October 2024<\/strong> \u2013 <em>Abbott<\/em> launched <strong>TEAM-HF<\/strong>, a novel clinical trial using AI and <strong>CardioMEMS\u2122 HF System<\/strong> to optimize early intervention strategies in heart failure patients, potentially leading to advanced therapies like <strong>HeartMate 3\u2122 LVAD<\/strong>.<\/p>\n\n\n\n<p><strong>August 29, 2024<\/strong> \u2013 <em>Renata Medical<\/em> got FDA approval for the <strong>Minima Growth Stent<\/strong>, uniquely designed for neonates and young children with congenital heart defects. It can expand as the child grows, solving a long-standing challenge in pediatric cardiology.<\/p>\n\n\n\n<p><strong>August 2024<\/strong> \u2013 <em>Boston Scientific<\/em> received the <strong>CE mark<\/strong> for the <strong>ACURATE Prime\u2122 Aortic Valve System<\/strong>, a next-generation TAVR solution advancing structural heart therapy in Europe.<\/p>\n\n\n\n<p><strong>July 2024<\/strong> \u2013 <em>FibriCheck<\/em> received FDA clearance in the <strong>Digital Health (DHX) category<\/strong> for its <strong>smartphone\/smartwatch ECG app<\/strong>, enabling remote detection of arrhythmias like atrial fibrillation and enhanced data sharing with physicians.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"418\" src=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/18163722\/Leading-Companies-in-the-Heart-Devices-1024x418.png\" alt=\"Leading-Companies-in-the-Heart-Devices\" class=\"wp-image-32504\" srcset=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/18163722\/Leading-Companies-in-the-Heart-Devices-1024x418.png 1024w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/18163722\/Leading-Companies-in-the-Heart-Devices-300x123.png 300w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/18163722\/Leading-Companies-in-the-Heart-Devices-150x61.png 150w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/18163722\/Leading-Companies-in-the-Heart-Devices-768x314.png 768w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/18163722\/Leading-Companies-in-the-Heart-Devices-1536x627.png 1536w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/18163722\/Leading-Companies-in-the-Heart-Devices-2048x836.png 2048w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-challenges-and-benefits-of-heart-devices\"><span class=\"ez-toc-section\" id=\"Challenges_and_Benefits_of_Heart_Devices\"><\/span>Challenges and Benefits of Heart Devices<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-challenges\"><span class=\"ez-toc-section\" id=\"Challenges\"><\/span>Challenges<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><strong>High Costs and Accessibility:<\/strong> Advanced heart devices, such as Total Artificial Hearts and Transcatheter Heart Valve Replacement systems, often come with significant costs, ranging from tens to hundreds of thousands of dollars. These expenses, coupled with surgical and follow-up care, can limit access, particularly in low-income regions or for uninsured patients, exacerbating healthcare disparities.<\/p>\n\n\n\n<p><strong>Risk of Complications: <\/strong>Despite technological advancements, devices like Heart Pump Devices and Heart Closure Devices carry risks of complications, including infections, bleeding, or device malfunctions. For example, ventricular assist devices may lead to blood clots, requiring careful monitoring and anticoagulation therapy, which can impact patient quality of life.<\/p>\n\n\n\n<p><strong>Lifelong Monitoring and Maintenance: <\/strong>Many heart devices, such as Congestive Heart Failure Treatment Devices and Tissue Heart Valves, require ongoing medical oversight to ensure functionality and detect issues like valve degeneration or battery depletion. This necessitates regular check-ups and potential device replacements, adding to patient burden and healthcare costs.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-benefits\"><span class=\"ez-toc-section\" id=\"Benefits\"><\/span>Benefits<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><strong>Life-Saving Interventions:<\/strong> Heart devices like Total Artificial Hearts and Heart Pump Devices provide critical support for patients with end-stage heart failure, extending life expectancy while awaiting transplants or serving as permanent solutions. These interventions have transformed outcomes for conditions previously considered untreatable.<\/p>\n\n\n\n<p><strong>Enhanced Quality of Life:<\/strong> Devices such as Cardiac Resynchronization Therapy units and Transcatheter Heart Valve Replacement systems alleviate debilitating symptoms like shortness of breath and fatigue, enabling patients to resume daily activities and improve their overall well-being.<\/p>\n\n\n\n<p><strong>Minimally Invasive Options:<\/strong> Advances in Structural Heart Devices and Heart Closure Devices allow for catheter-based procedures, reducing recovery times and complications compared to open-heart surgery. This is particularly beneficial for high-risk patients, such as the elderly or those with comorbidities.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-emerging-technologies\"><span class=\"ez-toc-section\" id=\"Emerging_Technologies\"><\/span>Emerging Technologies<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><strong>Bioresorbable Heart Devices: <\/strong>Researchers are developing bioresorbable stents and closure devices that dissolve naturally after restoring heart function, eliminating the need for long-term implants. These are particularly promising for Congenital Heart Defect Devices, reducing risks in pediatric patients as their hearts grow.<\/p>\n\n\n\n<p><strong>3D-Printed Heart Valves:<\/strong> Customized 3D-printed tissue heart valves, tailored to a patient\u2019s unique anatomy, are advancing through clinical trials. This technology enhances compatibility and durability, potentially revolutionizing Tissue Heart Valves and Transcatheter Heart Valve Replacement systems.<\/p>\n\n\n\n<p><strong>Wearable Heart Monitors with Cloud-Based Analysis: <\/strong>Next-generation Heart Sound Sensors are integrating with wearable devices that transmit real-time data to cloud platforms for AI-driven analysis. This enables early detection of heart conditions and supports remote monitoring, expanding telemedicine applications.<\/p>\n\n\n\n<p><strong>Gene-Editing Therapies Combined with Device Implants:<\/strong> Combining CRISPR-based gene therapies with heart devices, such as Congestive Heart Failure Treatment Devices, aims to address the underlying genetic causes of heart disease. Early trials suggest potential for long-term solutions, reducing reliance on mechanical interventions.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-conclusion\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span>Conclusion<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><strong><em>Heart devices have revolutionized cardiac care<\/em><\/strong>, offering life-saving solutions for conditions ranging from heart failure to congenital defects. From Total Artificial Hearts sustaining critically ill patients to minimally invasive Heart Closure Devices preventing strokes, these technologies have significantly improved survival rates and quality of life. Recent advancements, such as Medtronic\u2019s TAVR trial outcomes and Boston Scientific\u2019s strategic shifts, underscore the dynamic nature of this field.&nbsp;<\/p>\n\n\n\n<p>However, challenges like <strong>high costs, complications, and the need for lifelong monitoring<\/strong> highlight the importance of continued innovation. Emerging technologies, including bioresorbable devices and gene-editing therapies, promise to address these hurdles, paving the way for more accessible and effective treatments. To stay proactive about heart health, <em>readers are encouraged<\/em> to stay informed about these advancements and consult cardiologists for personalized care, ensuring a healthier future.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Heart disease continues to be a major global health concern, impacting countless lives and placing a significant burden on healthcare systems worldwide. According to the World Health Organization, cardiovascular diseases are responsible for approximately 17.9 million deaths each year, accounting for nearly one-third of all global deaths. These conditions, ranging from heart failure to congenital [&hellip;]<\/p>\n","protected":false},"author":20,"featured_media":32505,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17],"tags":[137,21542,21543,19084,183,20522,21320,20485,204,704,21516,21515,635,20091,20090,21780,2753,17021,16975,19087,19422,20554,20553,19486],"industry":[17226],"therapeutic_areas":[17242],"class_list":["post-32502","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","tag-cancer","tag-cardiac-resynchronization-therapy-devices","tag-cardiac-resynchronization-therapy-devices-market","tag-congenital-heart-defect-devices","tag-congestive-heart-failure","tag-congestive-heart-failure-chf-treatment-devices","tag-congestive-heart-failure-chf-treatment-devices-market","tag-congestive-heart-failure-treatment-devices","tag-delveinsight","tag-fda","tag-heart-closure-devices","tag-heart-closure-devices-market","tag-heart-failure","tag-heart-pump-devices","tag-heart-pump-devices-market","tag-heart-sound-monitor","tag-medical-device","tag-medical-devices-market","tag-medtech-market","tag-structural-heart-devices","tag-tissue-heart-valves","tag-transcatheter-heart-valve-replacement-devices","tag-transcatheter-heart-valve-replacement-devices-market","tag-ventricular-assist-devices","industry-medical-devices","therapeutic_areas-cardiovascular-diseases"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Innovative Heart Devices Transforming Cardiac Care<\/title>\n<meta name=\"description\" content=\"Explore how advanced heart devices, like artificial hearts and smart valves, are revolutionizing care and improving patient outcomes.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Innovative Heart Devices Transforming Cardiac Care\" \/>\n<meta property=\"og:description\" content=\"Explore how advanced heart devices, like artificial hearts and smart valves, are revolutionizing care and improving patient outcomes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-18T11:26:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-18T11:29:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/18164528\/feature-Exploring-Life-Saving-Heart-Devices_-Innovations-Transforming-Cardiac-Care.png\" \/>\n\t<meta property=\"og:image:width\" content=\"466\" \/>\n\t<meta property=\"og:image:height\" content=\"284\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Jatin Vimal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jatin Vimal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"12 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Innovative Heart Devices Transforming Cardiac Care","description":"Explore how advanced heart devices, like artificial hearts and smart valves, are revolutionizing care and improving patient outcomes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care","og_locale":"en_US","og_type":"article","og_title":"Innovative Heart Devices Transforming Cardiac Care","og_description":"Explore how advanced heart devices, like artificial hearts and smart valves, are revolutionizing care and improving patient outcomes.","og_url":"https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2025-06-18T11:26:08+00:00","article_modified_time":"2025-06-18T11:29:03+00:00","og_image":[{"width":466,"height":284,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/18164528\/feature-Exploring-Life-Saving-Heart-Devices_-Innovations-Transforming-Cardiac-Care.png","type":"image\/png"}],"author":"Jatin Vimal","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"Jatin Vimal","Est. reading time":"12 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care","url":"https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care","name":"Innovative Heart Devices Transforming Cardiac Care","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/18164528\/feature-Exploring-Life-Saving-Heart-Devices_-Innovations-Transforming-Cardiac-Care.png","datePublished":"2025-06-18T11:26:08+00:00","dateModified":"2025-06-18T11:29:03+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/c846f0323e948c55336d657b654f3158"},"description":"Explore how advanced heart devices, like artificial hearts and smart valves, are revolutionizing care and improving patient outcomes.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/exploring-life-saving-heart-devices-innovations-transforming-cardiac-care#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/18164528\/feature-Exploring-Life-Saving-Heart-Devices_-Innovations-Transforming-Cardiac-Care.png","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/18164528\/feature-Exploring-Life-Saving-Heart-Devices_-Innovations-Transforming-Cardiac-Care.png","width":466,"height":284,"caption":"exploring-life-saving-heart-devices-innovations-transforming-cardiac-care"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/c846f0323e948c55336d657b654f3158","name":"Jatin Vimal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/10dcf4b5071c366691525fa20af33b87e8a3897e6d0acc1a2b09a7b99b8d8ae1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/10dcf4b5071c366691525fa20af33b87e8a3897e6d0acc1a2b09a7b99b8d8ae1?s=96&d=mm&r=g","caption":"Jatin Vimal"},"sameAs":["https:\/\/www.delveinsight.com"]}]}},"author_meta":{"display_name":"Jatin Vimal","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/jatin"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/18164528\/feature-Exploring-Life-Saving-Heart-Devices_-Innovations-Transforming-Cardiac-Care-300x183.png","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Cancer<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Cardiac Resynchronization Therapy Devices<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Cardiac Resynchronization Therapy Devices Market<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Congenital Heart Defect Devices<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">congestive heart failure<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Congestive Heart Failure (CHF) Treatment Devices<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Congestive Heart Failure (CHF) Treatment Devices Market<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Congestive Heart Failure Treatment Devices<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">DelveInsight<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">FDA<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Heart Closure Devices<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Heart Closure Devices Market<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Heart failure<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Heart Pump Devices<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Heart Pump Devices Market<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Heart Sound Monitor<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">medical device<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Medical Devices Market<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">MedTech Market<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Structural Heart Devices<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Tissue Heart Valves<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Transcatheter Heart Valve Replacement Devices<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Transcatheter Heart Valve Replacement Devices Market<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Ventricular Assist Devices<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Cancer<\/span>","<span class=\"advgb-post-tax-term\">Cardiac Resynchronization Therapy Devices<\/span>","<span class=\"advgb-post-tax-term\">Cardiac Resynchronization Therapy Devices Market<\/span>","<span class=\"advgb-post-tax-term\">Congenital Heart Defect Devices<\/span>","<span class=\"advgb-post-tax-term\">congestive heart failure<\/span>","<span class=\"advgb-post-tax-term\">Congestive Heart Failure (CHF) Treatment Devices<\/span>","<span class=\"advgb-post-tax-term\">Congestive Heart Failure (CHF) Treatment Devices Market<\/span>","<span class=\"advgb-post-tax-term\">Congestive Heart Failure Treatment Devices<\/span>","<span class=\"advgb-post-tax-term\">DelveInsight<\/span>","<span class=\"advgb-post-tax-term\">FDA<\/span>","<span class=\"advgb-post-tax-term\">Heart Closure Devices<\/span>","<span class=\"advgb-post-tax-term\">Heart Closure Devices Market<\/span>","<span class=\"advgb-post-tax-term\">Heart failure<\/span>","<span class=\"advgb-post-tax-term\">Heart Pump Devices<\/span>","<span class=\"advgb-post-tax-term\">Heart Pump Devices Market<\/span>","<span class=\"advgb-post-tax-term\">Heart Sound Monitor<\/span>","<span class=\"advgb-post-tax-term\">medical device<\/span>","<span class=\"advgb-post-tax-term\">Medical Devices Market<\/span>","<span class=\"advgb-post-tax-term\">MedTech Market<\/span>","<span class=\"advgb-post-tax-term\">Structural Heart Devices<\/span>","<span class=\"advgb-post-tax-term\">Tissue Heart Valves<\/span>","<span class=\"advgb-post-tax-term\">Transcatheter Heart Valve Replacement Devices<\/span>","<span class=\"advgb-post-tax-term\">Transcatheter Heart Valve Replacement Devices Market<\/span>","<span class=\"advgb-post-tax-term\">Ventricular Assist Devices<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 11 months ago","modified":"Updated 11 months ago"},"absolute_dates":{"created":"Posted on Jun 18, 2025","modified":"Updated on Jun 18, 2025"},"absolute_dates_time":{"created":"Posted on Jun 18, 2025 4:56 pm","modified":"Updated on Jun 18, 2025 4:59 pm"},"featured_img_caption":"exploring-life-saving-heart-devices-innovations-transforming-cardiac-care","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/32502","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=32502"}],"version-history":[{"count":2,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/32502\/revisions"}],"predecessor-version":[{"id":32509,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/32502\/revisions\/32509"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/32505"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=32502"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=32502"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=32502"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=32502"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=32502"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}